BPG is committed to discovery and dissemination of knowledge
Articles in Press
2/4/2026 12:06:31 PM | Browse: 6 | Download: 0
| Category |
Dermatology |
| Manuscript Type |
Editorial |
| Article Title |
Fractional carbon dioxide laser preconditioning potentiates adipose-derived mesenchymal stem cell exosomes for diabetic wound repair
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Chun-Yi Wu, Xie-Hua Xiao and Jian-Guo Feng |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Sichuan Science and Technology Program |
No. 2025ZNSFSC0744 |
| Health Commission of Sichuan Province Medical Science and Technology Program |
No. 24QNMP040 |
| Luzhou Science and Technology Program |
No. 2025RCX002 |
|
| Corresponding Author |
Jian-Guo Feng, Associate Professor, PhD, Principal Investigator, Department of Anesthesiology, The Affiliated Hospital, Southwest Medical University, No.25th, Taiping Street, Luzhou, Luzhou 646000, Sichuan Province, China. fengjianguo@swmu.edu.cn |
| Key Words |
Angiogenesis.; Preconditioning; Fractional carbon dioxide laser; Exosomes; Mesenchymal stem cells; Diabetic wound healing |
| Core Tip |
This editorial highlight that fractional carbon dioxide (CO₂) laser pre-conditioning offers a novel, drug-free strategy to enhance the therapeutic quality of adipose-derived mesenchymal stem cell exosomes (Exos) for diabetic wound repair. We emphasize recent findings that this physical pre-conditioning strategy, utilizing clinically established and dose-tunable photothermal stimulation, enriches sphingosine-1-phosphate (S1P) cargo and activates endothelial S1P receptor 1/protein kinase B/hypoxia-inducible factor-1α signaling, thereby promoting improved angiogenesis and cytoprotection. This concept reframes fractional CO₂ lasers as a scalable, good manufacturing practice-compatible platform to “upgrade” Exos bioactivity for chronic diabetic wounds. |
| Citation |
Wu CY, Xiao XH, Feng JG. Fractional carbon dioxide laser preconditioning potentiates adipose-derived mesenchymal stem cell exosomes for diabetic wound repair. World J Diabetes 2026; In press |
 |
Received |
|
2025-12-02 00:57 |
 |
Peer-Review Started |
|
2025-12-03 09:18 |
 |
First Decision by Editorial Office Director |
|
2025-12-31 07:54 |
 |
Return for Revision |
|
2025-12-31 07:54 |
 |
Revised |
|
2026-01-14 03:34 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-02-04 02:48 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-02-04 12:06 |
 |
Articles in Press |
|
2026-02-04 12:06 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345